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oral administration of ferulic acid 
or ethyl ferulate attenuates retinal 
damage in sodium iodate-induced 
retinal degeneration mice
Masayuki Kohno1, Kunihiro Musashi2, Hanako ohashi ikeda3, tomohisa Horibe1, 
Aki Matsumoto1 & Koji Kawakami1 ✉
epidemiological studies indicate that the daily intake of antioxidants from a traditional Asian diet 
reduces the risk of developing age-related macular degeneration. Many of the phytochemicals that 
are abundant in whole grains exhibit a wide variety of biological activity such as antioxidant, anti-
inflammatory, and neuroprotective effects. Ferulic acid (FA) is a phenolic acid found in vegetables and 
grains that has therapeutic potential for diabetes mellitus, Alzheimer’s disease, and other diseases. 
We investigated the retinal protective effect of FA in a sodium iodate (NaIO3)-induced model of retinal 
degeneration. in a human retinal pigment epithelial cell line, fA attenuated H2o2-induced injury and 
lipopolysaccharide- or 7-ketocholesterol-induced inflammation. In mice, the oral administration of FA 
or its analog, ethyl ferulate, attenuated the morphological and functional features of naio3-induced 
retinal degeneration according to optical coherence tomography and electroretinography. our results 
demonstrate that the oral administration of FA provides protective effects to the retina, suggesting 
that the intake of fA as a daily supplement or daily healthy diet containing rich vegetables and whole 
grains may prevent age-related macular degeneration.
Age-related macular degeneration (AMD) is the primary cause of blindness in the elderly in Western countries1. 
AMD is a progressive neurodegenerative disease affecting the macula that results in irreversible visual impair-
ment. The late stages of AMD can be classified into (i) wet and (ii) dry forms: (i) choroidal neovascularization 
with newly formed blood vessels in the macular region; and (ii) geographic atrophy with major loss of the ret-
inal pigment epithelium and choriocapillaris2. Wet AMD can be treated by repeated intravitreal injections of 
anti-vascular endothelial growth factor agents, but no effective treatment exists for dry AMD. AMD is a multi-
factorial disease, with aging, genetic factors, oxidative stress, light exposure, and inflammation contributing to 
its pathogenesis3.
Several modifiable lifestyle factors are associated with a lower prevalence of AMD, including certain healthy 
diets, physical activity, and not smoking4. The Western diet has been associated with an increased risk of develop-
ing AMD5. Conversely, the traditional Asian diet and the Mediterranean diet are associated with decreased risks 
of developing AMD5,6. Some clinical studies have shown that the progression of AMD can be slowed with lutein/
zeaxanthin supplements7,8.
Plants produce various phytochemicals as antioxidants in order to protect themselves against ultraviolet 
radiation from sunlight. Many phytochemicals, such as polyphenols and phenolic acids, are included in vegeta-
bles, fruits, grains, and tea leaves, and have been proposed for the treatment of various chronic and intractable 
diseases9.
Whole grains are rich sources of various phytochemicals, and their consumption has been associated with 
a reduced risk of developing major chronic diseases such as cancer, diabetes, and cardiovascular disease10. In 
fact, brown rice and one of its components, γ-oryzanol, improve glucose metabolism and attenuate the pref-
erence for dietary fat in mice fed a high-fat diet11. Rice bran is produced by milling rice and is an important 
source of various phytochemicals, and it is especially rich in the phenolic compounds γ-oryzanol and ferulic acid 
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(FA)12. γ-Oryzanol is a combined ester of FA and phytosterols. FA is the main metabolite of γ-oryzanol and has 
been proposed as a potential treatment for many diseases including cancer, diabetes, cardiovascular disease, and 
Alzheimer’s disease (AD)13. AD is a late-onset, neurodegenerative disease that shares several clinical and patho-
logical features with AMD. There is growing evidence of epidemiological, molecular, and clinical links between 
AD and AMD14.
FA causes the unpleasant bitter and astringent taste of alcoholic beverages such as sake; however, its analog, 
ethyl ferulate (EF), contained in sake and sake mash, has a more pleasant taste than FA15. EF reportedly has anti-
oxidant and anti-inflammatory effects in vitro and in vivo by oral administration16,17. Because EF has an ester 
group, it is more lipophilic and has higher cell membrane and blood-brain barrier permeability than FA. In this 
study, we demonstrated the protective effect of FA and EF in a mouse model of retinal degeneration.
Results
fA attenuates H2o2-induced injury in ARPE-19 cells. From some reports, FA has been shown to be 
effective over a relatively wide concentration range, and based on this information, we determined the FA con-
centration of the vitro experiment13,18,19. To investigate whether FA could attenuate oxidative stress in the retina, 
we assessed whether FA reduced H2O2-induced injury in a human retinal pigment epithelial cell line (ARPE-19 
cells). Furthermore, we examined differences in the cytoprotective effect of FA before and after H2O2 exposure for 
1 h. FA (0.5 or 1 mM) did not affect the viability of ARPE-19 cells (column 1 in Fig. 1), and 0.4 mM H2O2 exposure 
for 1 h caused a 40–50% decrease in cell viability. Treatment with FA attenuated cell damage, and pretreatment 
with FA was more effective than post-treatment with FA (columns 2 and 3 in Fig. 1).
FA attenuates lipopolysaccharide (LPS)- or 7-ketocholesterol (7KCh)-induced inflammation in 
ARPE-19 cells. Many phytochemicals, including FA, reportedly have anti-inflammatory effects, and FA has 
been shown to be effective over a relatively wide concentration range in anti-inflammatory assay20,21. To inves-
tigate whether FA could attenuate inflammation in the retina, we assessed whether it could reduce interleukin 
(IL)-6 production in ARPE-19 cells exposed to LPS or 7KCh. Exposure to LPS or 7KCh for 48 h increased IL-6 
production in ARPE-19 cells, and treatment with FA attenuated its production (Fig. 2).
Figure 1. Effect of FA on H2O2-induced injury in ARPE-19 cells. (1) ARPE-19 cells were treated with FA for 
3 days without exposure to H2O2. (2) ARPE-19 cells were pretreated without or with FA for 1 h before a 1-h 
exposure to 0.3 mM H2O2. The cells were incubated in fresh medium for 3 days. (3) ARPE-19 cells were exposed 
to 0.3 mM H2O2 for 1 h. The medium was replaced, FA was added, and the cells were incubated for 3 days. Data 
represent the mean ± standard deviation (SD) of technical replicates from triplicate determinations, and the 
assay was repeated three times with similar results to confirm the result. **p < 0.01 vs. None (Dunnett’s test).
Figure 2. Effect of FA on LPS- or 7KCh-induced inflammation in ARPE-19 cells. ARPE-19 cells were cultured 
with LPS or 7KCh for 48 h with or without 0.5 or 1.5 mM FA. Data represent the mean ± SD of technical 
replicates from triplicate determinations, and the assay was repeated three times with similar results to confirm 
the result. **p < 0.01 vs. None (Dunnett’s test).
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Oral treatment with FA attenuates N-methyl-N-nitrosourea (MNU)-induced retinal degen-
eration in mice. For pharmacological induction of experimental retinal degeneration, MNU or sodium 
iodate (NaIO3) has been used22,23. First, we investigated the effect of FA against MNU-induced retinal degen-
eration. Mice (ddY) were injected with MNU interperitoneally at a dose of 70 mg/kg body weight. FA (10 mg/
kg/day) was administered orally using a feeding needle once a day from the first day of MNU injection to 4 days 
after. Quantification of the outer nuclear layer (ONL) and total retina demonstrated retinal degeneration by day 
4 in mice treated with MNU compared to control, and treatment with oral FA attenuated the MNU-induced 
damage (Supplementary Fig. S1). Next, we confirmed reproducibility of the effect of FA against MNU-induced 
retinal degeneration. Mice were injected with MNU interperitoneally at a dose of 60 mg/kg body weight. FA 
was administered orally using a feeding needle twice a day or interperitoneally once a day from the first day of 
MNU injection to 4 days after. Quantification of the ONL and total retina demonstrated retinal degeneration 
by day 4 in mice treated with MNU compared to control, and treatment with FA attenuated the MNU-induced 
damage (Supplementary Fig. S2). After conducting the second animal experiment, MNU was discontin-
ued at Sigma-Aldrich and no longer available. We obtained another MNU (containing water) from Toronto 
Research Chemicals, but its damage activity was weaker than the activity of the sigma-MNU (Supplementary 
Fig. S3). In such a state, it was judged that it would be difficult to evaluate the efficacy of FA, and the retinal 
degeneration-inducing agent was changed from MNU to NaIO3.
oral pretreatment with fA attenuates naio3-induced retinal degeneration in mice. Next, 
we investigated the effect of oral FA pre- or post-treatment on NaIO3-induced retinal degeneration. C57BL/6 
mice were injected with NaIO3 interperitoneally at a dose of 40 mg/kg body weight. FA was administered orally 
using a water bottle (30 mg/kg/day), and we divided FA treatment into pre-treatment from 3 days before NaIO3 
injection to 1 day after and post-treatment from 1 day after NaIO3 injection to 15 days after (Supplementary 
Table S1). Spectral-domain optical coherence tomography (SD-OCT) images revealed that the cumulative thick-
ness of the outer retina (OR, from the outer plexiform layer to the retinal pigment epithelium) and the cho-
roid layer (ORC) was significantly reduced at 15 days after administration of NaIO3 (H/H group, pretreatment 
with H2O/post-treatment with H2O) compared with the control group. Pre-treatment with FA attenuated the 
NaIO3-induced retinal damage and suppressed the thinning of the ORC (Fig. 3a,b). On day 15, b-wave amplitude 
Figure 3. Oral treatment with FA attenuates NaIO3-induced retinal degeneration in mice. (a) Representative 
SD-OCT images of control mice and mice treated with various combinations of H2O or FA for 15 days after 
NaIO3 administration. SD-OCT images showing the cross-sectional retinal thickness of mice in each group. The 
thickness of the ORC was measured from the OPL until the choroid. H:H2O; F: FA. (b) Quantitative analysis 
of ORC thickness by SD-OCT for each group. Data are shown as the mean ± SD (4 eyes in the control group; 8 
eyes in the NaIO3-treated groups). **p < 0.01 vs. H/H (Dunnett’s test). (c) Oral pretreatment with FA attenuates 
NaIO3-injured visual function at 15 days after NaIO3 injection. Photopic ERG responses of b-waves elicited by 
light at an intensity of 30 cds/m2 were recorded at 15 days after NaIO3 injection. **p < 0.01 vs. H/H (Dunnett’s 
test).
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was strongly reduced in NaIO3-exposed retina compared with the control group. Pre-treatment with FA (F/H) 
attenuated NaIO3-induced retinal dysfunction and increased electroretinogram (ERG) responses (Fig. 3c), and 
more effectively attenuated the NaIO3-induced retinal damage compared to post-treatment with FA (H/F).
ef attenuates H2o2-induced injury in ARPE-19 cells. To investigate whether the FA analog EF could 
attenuate oxidative stress in the retina, we assessed whether FA could reduce H2O2-induced injury in ARPE-19 
cells (Fig. 4a). EF (0.02 or 0.01 mM) did not affect the viability of ARPE-19 cells. Exposure to 0.4 mM H2O2 for 1 h 
caused a 50–60% loss in cell viability, and treatment with EF attenuated this cell damage (Fig. 4b).
oral treatment with ef attenuates naio3-induced retinal degeneration in mice. Next, we 
investigated the effect of EF treatment on NaIO3-induced retinal degeneration. C57BL/6 mice were injected with 
NaIO3 interperitoneally at a dose of 40 mg/kg body weight. EF was administered orally using a water bottle from 
3 days before NaIO3 injection to 14 days after (30 mg/kg/day).
On day 14, b-wave amplitude was strongly reduced in NaIO3-exposed retina compared with the control group, 
and treatment with EF attenuated NaIO3-induced retinal dysfunction and increased ERG responses (Fig. 5a). 
SD-OCT images revealed that the thickness of the ORC was significantly reduced at 14 days after NaIO3 injection 
compared with the control group. However, the thickness of the ORC in SD-OCT images of NaIO3-injected mice 
did not differ between H2O and EF administration (Fig. 5b). To validate the retinal imaging results, degeneration 
profiles were measured in histological sections of the retina collected at 14 days after NaIO3 injection. In the retina 
of NaIO3-injected mice, obvious damage was found in the ONL, cone and rod layer, and retinal pigmented epithe-
lium, forming a series of irregular folds in the outer retina (Fig. 5c). The rate of irregularities (cumulative retinal 
length exhibiting irregular ONL vs. total retinal length) in histological sections cutting across the optic disc was 
measured18. Treatment with EF attenuated the NaIO3-induced rate of irregularities in the outer retina (Fig. 5d).
Discussion
MNU and NaIO3 have retinal specific toxicity, and we selected H2O2 in consideration of not only AMD but also 
its potential application to other diseases involving oxidative stress damage. H2O2 is a typical oxidative stress 
inducer and is used for in vitro evaluation of many useful substances. NaIO3 is a stable oxidant that selectively 
damages the retinal pigmented epithelium following its systemic delivery, resulting in retinal degeneration. The 
retinal toxicity of NaIO3 has been demonstrated in various animal species, including sheep24, rabbits, rats25, and 
mice26, using various doses and administration routes. NaIO3 has been used widely to evaluate neuroprotective 
treatments in preclinical animal models of retinal degeneration and geographic atrophy27. As shown by Tsuruma 
et al., MNU elevated reactive oxygen species (ROS) in rod and cone photoreceptor cells and induces photore-
ceptor cell death in vitro, and Edaravone scavenged ROS production in a concentration-dependent manner, and 
reduced MNU-induced retinal degeneration in mice28. Edaravone might inhibit MNU-induced photoreceptor 
cell degeneration by its ROS-scavenging activity. Additionally, it is reported that FA or EF has ROS-scavenging 
activity and reduces ROS generation in synaptosome17,29. The retinal protective effect of FA and EF is considered 
to be similar to the above mechanism by their ROS-scavenging activity.
Pre-treatment with FA attenuated NaIO3-induced retinal damage more effectively than post-treatment with 
FA (Fig. 3c). The beneficial effects of phytochemicals, such as green tea catechins and chrysophanol, have been 
shown in retinal degenerative models induced with NaIO3 or MNU; however, they were administered orally 
Figure 4. Effect of EF on H2O2-induced injury in ARPE-19 cells. (a) Chemical structures of FA and EF. Square 
in EF indicate the different portion for chemical structure from FA. (b) ARPE-19 cells were treated with EF for 
24 h before a 1-h exposure to 0.4 mM H2O2. The cells were incubated in fresh medium for 24 h. Data represent 
the mean ± SD of technical replicates from triplicate determinations, and the assay was repeated three times 
with similar results to confirm the result. **p < 0.01, *p < 0.05 vs. None (Dunnett’s test).
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before NaIO3 or MNU injection22,23. Yu et al. reported that a daily grape diet could prevent age-related retinal 
pigment epithelium actin damage and blindness in mice lacking the αvβ5 integrin receptor30. The beneficial effect 
of a daily grape diet was shown during young adulthood (3–6 months of age) or midlife (6–9 months of age), but 
not during later life (9–12 months of age). Daily prophylactic treatment with phytochemicals may be required so 
they could exert an inhibitory effect on the progression of retinal degeneration. As for the inhibitory effect against 
NaIO3-induced retinal degeneration, EF showed a slightly weaker effect compared to FA, though EF has greater 
cell membrane permeability than FA. It is considered that some causes of this effect might include differences in 
their bioavailability. Kikuzaki et al. reported that the radical scavenging activity on 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) decreased in the order ferulic acid > ferulic acid esters, and the higher effectiveness of ferulic acid 
than its esters might be influenced by the difference in their partition coefficients in the n-octanol/PBS sys-
tem explained by their affinity with lipid. Ferulic acid suppressed formation of hydroperoxide more than alkyl 
ferulates16.
FA can be quickly absorbed (T max = 24 min) and eliminated (t1/2 = 42 min), and its oral bioavailability is 
~20% in humans31,32. The oral administration of (-)-epigallocatechin gallate reportedly inhibits retinal degenera-
tion in rats18. As the blood−retina barrier permeability of FA and (-)-epigallocatechin gallate is relatively high, we 
assume that FA could reach the retina33. FA and EF have free radical scavenging activity and can increase superox-
ide dismutase and catalase activity to promote the detoxification of reactive oxygen species. They can upregulate 
the expression of heat shock protein 70 and heme oxygenase-1 to exert a cytoprotective effect on damaged cells13. 
FA inhibits the production of inflammatory cytokines, such as IL-6, IL-1β, and tumor necrosis factor-α, in vari-
ous animal models of hepatocytic and aortic inflammation and ulcerative colitis34. The representative mechanism 
of anti-inflammation is attributed to the ability of hydroxycinnamic acids including FA to inhibit the NF-κB 
pathway and suppress the expression of COX-2 and iNOS35.
It is considered that the therapeutic potential of FA includes antioxidant, antihypertensive, antihyperlipi-
demic, vasodilation, and hypoglycemic effects in cardiovascular disease34. The oral administration of FA reduces 
the levels of triglycerides, cholesterols, and blood pressure in hypertensive rats, and the reduction of blood pres-
sure is observed at 1–2 h after administration36. In diabetic rats, oral FA treatment restores blood glucose and 
serum insulin levels and insulin and glucose tolerance to their normal range37. Chowdhury et al. showed that 
FA is sufficiently potent to provide protection to the heart from oxidative and endoplasmic reticulum stress by 
circumventing hyperglycemia, ameliorating cardiac damage markers, regulating the intracellular redox balance, 
Figure 5. Oral treatment with EF attenuates NaIO3-induced retinal degeneration in mice. (a) Oral pretreatment 
with EF attenuates NaIO3-injured photoreceptor function. Photopic ERG responses of b-waves elicited by light 
at an intensity of 30 cds/m2 were recorded at 14 days after NaIO3 injection. **p < 0.01, * p < 0.05 versus H2O 
(Dunnett’s test). (b) Quantitative analysis of ORC thickness by SD-OCT for each group at 14 days after NaIO3 
injection. (c,d) Evaluation of the damage in ONL lesions of HE-stained retinal sections of NaIO3-induced mice 
treated with H2O or EF. (c) Representative images of HE-stained retinal sections of mice treated without or with 
NaIO3. (d) Damage rate of ONL lesions in NaIO3-induced mice treated with H2O or EF. Data are shown as the 
mean ± SD (4 eyes in the control group; 8 eyes in the NaIO3-treated group). *p < 0.05 vs. H2O (Student’s t-test).
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and attenuating the eIF-2a- and caspase 12-activated endoplasmic reticulum stress-induced apoptotic pathway in 
streptozotocin-induced diabetic rats38.
AD is a neurodegenerative disorder characterized by the progressive loss of memory, cognitive dysfunction, 
and mood disorders. The pathogenesis of AD is associated with the formation of senile plaques consisting of 
aggregates of amyloid β (Aβ). FA inhibits Aβ monomer-to-oligomer transition and the formation of Aβ fibrils39,40. 
In many AD rodent models, FA attenuates neuroinflammation and improves some dementia-like symptoms 
related to cognitive performance13,41,42. Because the intravenous administration of FA has protective effects 
against the neuronal cell death induced by cerebral ischemia in rats43,44, it is speculated to be able to cross the 
blood-brain barrier34.
AD shares similar environmental risk factors with AMD, including smoking, hypertension, hypercholester-
olemia, and an unhealthy diet14. Both diseases share similar cellular pathology, including oxidative stress and 
inflammation, and the detrimental deposition of Aβ in the ocular drusen and senile plaques in histopathologic 
features45. In contrast, some epidemiological research data provide evidence that there is no positive association 
between AMD and dementia or AD46. The oral administration of FA for 6 months was shown to reduce Aβ depo-
sition in an amyloid precursor protein and presenilin 1 double transgenic mouse model of AD41.
To ingest FA, a diet of whole grains and vegetables and supplements of FA are suitable approaches. FA is the 
main metabolite of γ-oryzanol, which has antiinflammation and antioxidation effects, and was marketed under 
the name “Hi-Z” by Otsuka Pharmaceutical Co., Ltd. in 1970 for the treatment of hyperlipidemia and psychoso-
matic disorders (climacteric disturbance and irritable bowel syndrome)47. There are sufficient data available for 
previously marketed drugs such as Hi-Z on their pharmacokinetics, metabolism, and toxicity in humans. Drug 
repositioning is the process of discovering new uses for marketed drugs in a rapid and cost-effective manner and 
has become a popular strategy for drug discovery and development in recent years48. Daily dietary improvements, 
intake of FA supplements, and prescription of Hi-Z for repositioned indications might be able to slow age-related 
functional decline in AMD and AD.
Japanese people traditionally ate poorly-refined rice with various millets as a staple food containing various 
and rich antioxidants such as FA and γ-oryzanol until the Western diet was adopted widely in Japan. The tra-
ditional Japanese diet is associated with a lower prevalence of cardiovascular disease and AMD and increased 
longevity49,50. The traditional Japanese diet and the Mediterranean diet are representative healthy diets that have 
many common characteristic components such as whole grains, large portions of vegetables, fruits, legumes, and 
fish, and small portions of meat. Higher adherence to the Mediterranean diet is associated with a lower risk of 
incident-advanced AMD, and the traditional Asian diet is significantly associated with a reduced risk of early and 
advanced AMD. In contrast, the Western diet, which is characterized by a high intake of red meat and high-fat 
dairy products, is significantly associated with an increased risk of early and advanced AMD5,51. The recom-
mended supplements for AMD include a combination of antioxidants (vitamins C and E, lutein, and zeaxanthin). 
However, in individuals who are reluctant to improve their diet, get more exercise, or quit smoking, the daily use 
of these recommended supplements might not be associated with a decreased risk of AMD. A healthy daily diet 
containing various whole grains and vegetables rich in antioxidants might be protective against AMD, slow the 
progression of AMD and other age-related diseases, and be associated with increased longevity50.
The mechanism by which an improvement in diet and lifestyle reduces the risk of AMD is unclear. Rowan 
et al. demonstrated that the consumption of a high-glycemia (HG) diet resulted in many AMD features in aged 
mice compared with a low-glycemia (LG) diet and that switching from the HG to the LG diet arrested or reversed 
the AMD features52. The composition of the gut microbiota is different between HG and LG diets, and the LG 
diet was shown to induce the production of metabolites that protected against AMD, including serotonin, by the 
gut microbiota. The traditional Asian diet and the Mediterranean diet contain fermented foods such as miso and 
cheese. FA is linked with a variety of carbohydrates such as glycosidic conjugates in grains. The carbohydrates 
covalently conjugated to FA can be administered orally, after which they are enzymatically hydrolyzed by the gut 
microbiota or liver metabolism and released in their free form. Lower-glycemic diets containing whole grains 
such as brown rice as a staple food can confer the daily recommended intake of FA and would help to protect 
against the development of AMD.
Methods
Materials. 7KCh and MNU were purchased from Sigma–Aldrich Japan (Tokyo, Japan), MNU (containing 
water) from Toronto Research Chemicals, hydroxypropyl-β-cyclodextrin (HPBCD) from Cayman Chemical 
(Ann Arbor, MI), LPS from Wako Pure Chemical Industries (Osaka, Japan), NaIO3 from Nacalai Tesque (Kyoto, 
Japan), FA and EF from Tokyo Chemical Industry (Tokyo, Japan), and other reagents from Nacalai Tesque or 
Sigma. All reagents were “reagent grade.” After conducting the second animal experiment (Supplementary 
Fig. S2), MNU was discontinued at Sigma-Aldrich and no longer available.
cell culture. Human retinal pigment epithelial cell line ARPE-19 cells (American Type Culture Collection, 
Manassas, VA) were cultured in a humidified atmosphere (37 °C, 5% CO2) in Dulbecco’s modified Eagle’s medium 
and F-12 nutrient mixture (Nacalai Tesque) supplemented with 10% heat-inactivated fetal bovine serum and 100 
μg/mL penicillin/streptomycin. The cells were passaged by trypsinization every 2 to 3 days. Each experiment was 
repeated at least 3 times.
cell viability analysis. ARPE-19 cells plated in a 96-well plate were treated (1) with or without FA for 3 days; 
(2) with or without FA for 1 h before a 1-h exposure to 0.3–0.4 mM H2O2 with fresh medium replaced every day 
for 3 days; (3) without drugs for 1 h before a 1-h exposure to 0.3–0.4 mM H2O2 with fresh medium containing FA 
or none replaced every day for 3 days. At the end of the incubation period, cell viability was assessed by WST-8 
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solution (Cell Count Reagent SF; Nacalai Tesque). The cells were incubated with WST-8 solution for 1–2 h and 
scanned at 450 nm with a microplate reader (Glow Max; Promega, Tokyo, Japan).
ELISA. The level of secreted IL-6 in conditioned medium from ARPE-19 cell culture was measured at 48 h 
after treatment with 40 μM 7KCh complexed with HPBCD53 and 2.5 μg/mL LPS using an ELISA Duoset (R&D 
Systems, Minneapolis, MN). Protein levels were measured in triplicate.
experimental animals. All experiments were performed according to the ethical guidelines of the Kyoto 
University Animal Research Committee. The protocol was approved by the Kyoto University Animal Research 
Committee (permission number: Med Kyo 17082). All mice were maintained under a 14-h light/10-h dark cycle 
and fed ad libitum. Adult female C57BL/6 mice (weight, 25–30 g) were obtained from Nihon SLC (Shizuoka, 
Japan). Before ERG and SD-OCT image acquisition, the mice were anesthetized by an intraperitoneal injection of 
medetomidine, butorphanol, and midazolam (0.75, 5, and 4 mg/kg body weight, respectively). Pupils were dilated 
with tropicamide and phenylephrine eye drops (0.5% each).
pharmacological induction of retinal degeneration. Retinal degeneration was induced as previously 
reported15,16. Briefly, MNU or NaIO3 was dissolved in saline and injected interperitoneally at a dose of 60 or 
40 mg/kg body weight, respectively. In the control group, the mice were injected interperitoneally with saline.
Administration of fA and ef. We measured the amount of water that the mice drank with ad libitum 
access in pilot experiments and prepared FA and EF solutions (water containing 0.2 mg/mL FA or EF) aiming 
for the administration of 30 mg/kg/day of FA or EF. The mice were given oral FA, EF, or water only using a water 
bottle from 3 days before NaIO3 injection to 2 weeks after it.
eRG. ERG using a gold-loop corneal electrode with a light-emitting diode (Mayo Corp., Inazawa, Japan) was 
performed54. A reference electrode was placed in the mouth, and a ground electrode was placed in the tail. Stimuli 
were produced with a light-emitting diode stimulator (Mayo Corp.). Then, the ERG response signals were ampli-
fied (PowerLab 2/25; AD Instruments, New South Wales, Australia). The photopic ERG responses of b-waves elic-
ited by light at an intensity of 30 cds/m2 were recorded at 2 weeks after NaIO3 administration. B-wave amplitudes 
were analyzed using Chart & Scope software (AD Instruments).
SD-oct acquisition and measurement of retinal thickness. SD-OCT examinations using Multiline 
OCT (Heidelberg Engineering, Heidelberg, Germany) in C57BL/6 mice were performed at 2 weeks after NaIO3 
injection. A 25-diopter adaptor lens was placed on the objective lens of the Multiline OCT to focus on the mouse 
retina. Outer retina thickness was measured from the outer plexiform layer until the retinal pigmented epithe-
lium. However, as choroidal structures and photoreceptor layer damaged by NaIO3 cannot be reliably detected in 
pigmented retinas such as those of C57BL/6 mice55,56, we evaluated structural degeneration as the thickness of the 
ORC instead of the outer retina. The ORC was measured from the outer plexiform layer until the choroid using 
linear scan images near the optic nerve head. The resulting SD-OCT images were imported into ImageJ software 
(National Institutes of Health, Bethesda, MD) to measure ORC thickness.
Histological analysis. On post-injection day 15, the mice were sacrificed by cervical dislocation. Their 
eyes were removed and fixed in SUPER FIX rapid fixative solution (Kurabo, Osaka, Japan). Fixed eyes were 
paraffin-embedded 5-μm sections were stained with hematoxylin and eosin (HE). Tissue section preparation and 
HE staining were entrusted to the Kyoto Pathology Laboratory. The images were captured using a BX-51 micro-
scope equipped with a DP-25 CCD camera (Olympus, Tokyo, Japan).
Statistical analysis. Statistical differences were determined using the unpaired Student’s t-test between two 
groups, or analysis of variance and then Dunnett’s test for the comparison of multiple groups by JMP Pro Ver.12 
(SAS Institute, Cary, NC). P  <  0.05 was considered significant.
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